Metastases Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Metastases stocks.

Metastases Stocks Recent News

Date Stock Title
May 11 AMGN We Wouldn't Be Too Quick To Buy Amgen Inc. (NASDAQ:AMGN) Before It Goes Ex-Dividend
May 10 AMGN 5 Stocks Driving Dow's Market-Beating Performance
May 9 AMGN AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
May 9 YMAB Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript
May 9 AMGN CytomX slides after early data for Amgen-partnered cancer drug
May 9 YMAB Y-mAbs: There's A Ceiling Here Somewhere
May 9 AMGN Q1 2024 CytomX Therapeutics Inc Earnings Call
May 9 VCYT Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount?
May 9 YMAB Y-mAbs Therapeutics Inc (YMAB) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
May 9 YMAB Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
May 8 VCYT Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript
May 8 YMAB Y-mAbs Therapeutics, Inc. (YMAB) Q1 2024 Earnings Call Transcript
May 8 YMAB Y-mAbs Therapeutics down 18% as Q1 results disappoint
May 8 VCYT Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
May 8 VCYT Q1 2024 Veracyte Inc Earnings Call
May 8 VCYT Veracyte Inc (VCYT) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Revenue ...
May 8 VCYT Veracyte, Inc. (VCYT) Q1 2024 Earnings Call Transcript
May 7 YMAB Y-mAbs Therapeutics Reports Q1 2024 Results: Aligns with EPS Projections, Misses Revenue Estimates
May 7 VCYT Veracyte Inc (VCYT) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strong Test Performance
May 7 YMAB Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Misses Revenue Estimates
Metastases

Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, are metastases (mets). It is generally distinguished from cancer invasion, which is the direct extension and penetration by cancer cells into neighboring tissues.Cancer occurs after cells are genetically altered to proliferate rapidly and indefinitely. This uncontrolled proliferation by mitosis produces a primary heterogeneic tumour. The cells which constitute the tumor eventually undergo metaplasia, followed by dysplasia then anaplasia, resulting in a malignant phenotype. This malignancy allows for invasion into the circulation, followed by invasion to a second site for tumorigenesis.
Some cancer cells known as circulating tumor cells acquire the ability to penetrate the walls of lymphatic or blood vessels, after which they are able to circulate through the bloodstream to other sites and tissues in the body. This process is known (respectively) as lymphatic or hematogenous spread. After the tumor cells come to rest at another site, they re-penetrate the vessel or walls and continue to multiply, eventually forming another clinically detectable tumor. This new tumor is known as a metastatic (or secondary) tumor. Metastasis is one of the hallmarks of cancer, distinguishing it from benign tumors. Most cancers can metastasize, although in varying degrees. Basal cell carcinoma for example rarely metastasizes.When tumor cells metastasize, the new tumor is called a secondary or metastatic tumor, and its cells are similar to those in the original or primary tumor. This means that if breast cancer metastasizes to the lungs, the secondary tumor is made up of abnormal breast cells, not of abnormal lung cells. The tumor in the lung is then called metastatic breast cancer, not lung cancer. Metastasis is a key element in cancer staging systems such as the TNM staging system, where it represents the "M". In overall stage grouping, metastasis places a cancer in Stage IV. The possibilities of curative treatment are greatly reduced, or often entirely removed when a cancer has metastasized.

Browse All Tags